Growth Hormone Therapy in Liver Cirrhosis | MicrobiomeTrials← Back to trialsNCT03420144
Growth Hormone Therapy in Liver Cirrhosis
CompletedPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2018-01-15Est. Completion: 2020-06-30
Enrollment target: 76 participants Locations- Post Graduate Institute of Medical Education and Research, Chandigarh, India
Other microbiome trials you might be interested in
Liver Diseases
This study integrates and evaluates a series of novel MRI methods for quantifying blood perfusion and tissue microstruct…
Madison, United StatesEst. completion May 2029
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
The newly adapted definition for MASLD includes evidence for hepatic steatosis by imaging or biopsy with at least one of…
Sohag, EgyptEst. completion Jan 1, 2027
Post-hepatectomy Hypoalbuminemia
Rice-derived recombinant human serum albumin (OsrHSA) possesses an identical primary, secondary, and higher-order struct…
Wuhan, ChinaEst. completion Jul 7, 2027